Speaker(s): 

Angela Schreck RRT-NPS, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the function and indications for HFOV 3100A in the neonatal population
• Explain the difference between PPHN and MAS and treatment differences for each disease when using the HFOV 3100A int the neonatal population
• Describe the ABG and CXR interpretation based on PPHN and MAS and how to manage a patient correctly when transitioning from conventional to HFOV ventilation 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Katie Ritz RRT-NPS, Katelyn Green, Mark Williams, RN, BSN, and Dr Ronald Wong, DO have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None